European Neurofibromatosis Conference 2026

An important international medical-scientific congress entirely dedicated to research into neurofibromatosis and related disorders. The event brings together clinicians, geneticists, biotechnological researchers, and patient representatives to discuss the latest clinical results, emerging therapies, and psychosocial care models.

Patient involvement in medical research and care

Medical science is making significant progress in unraveling rare genetic disorders through intensified international collaboration. This scientific congress focuses specifically on integrating the patient perspective into clinical research lines. By bringing doctors and patients into direct dialogue, a holistic approach is created that can significantly accelerate the development of targeted treatments.

Scientific sessions and molecular innovation

The intensive program is structured around various medical and molecular disciplines. Participants examine the latest breakthroughs in understanding and treating Neurofibromatosis type 1 (NF1), NF2-related disorders, and schwannomatosis. In addition to genetic presentations, there is ample attention paid to clinical oncological aspects, innovative drug studies, and the psychosocial impact of the disease on patients’ daily lives. Interactive panels and poster presentations offer young scientists the opportunity to showcase their work.

The target audience of this medical congress

This meeting is specifically designed for clinical geneticists, oncologists, neurologists, pediatricians, and specialized surgeons. In addition, the congress is an essential platform for biomedical scientists, nurses, and representatives of international patient organizations. The multidisciplinary setup encourages the building of valuable professional networks across national borders.

Tags